INTRODUCTION
In recent years, general multipurpose scoring systems for the evaluation of the intensive care units (ICUs) using logistic regression models have become the cornerstone of performance evaluation since they allow the estimation of outcome probabilities that can be later related to actual death rates as an indicator of the effectiveness of care. This relationship between actual and predicted outcomes was used in the comparison of hospital mortality rates, using the difference between the observed mortality and that predicted by a logistic regression model, controlling for some case mix factors [1, 2] . Several investigators proposed the use of the ratio between observed and predicted deaths (standardised mortality ratio, SMR) under the assumption that, although the ICUs admit very heterogeneous groups of patients with large differences in age, previous health status (e.g. chronic diseases) and acute health status (e.g. admission diagnosis; presence and level of physiologic derangement), the actually existent severity scores can account for most of these characteristics [3] .
The new Simplified Acute Physiology Score (SAPS II) was described in 1993 by Le Gall et al. [4] , based on a European/North American multicenter study. It was developed and validated in a cohort of 12997 patients from 110 hospitals in Europe and 27 in North America. This model includes 17 variables: 12 physiology variables (weighted according with their degree of deviation from normal value ranges); age; type of admission (medical and scheduled/unscheduled surgery); and three underlying diagnosis (acquired immunodeficiency syndrome, metastatic cancer and hematologic malignancy) chosen and weighed by logistic regression. The worst values for all variables are collected during the first 24 hours after admission to the ICU, their weights are summed and the final result is the SAPS II score. A logistic regression equation enables the conversion of the score into a probability of death in the hospital.
The second version of the Mortality Probability Models (MPM II) was described in 1993 by Lemeshow et al. [5] , based on the same database as SAPS II plus data collected from six ICUs in four teaching hospitals in the United States. In this model, the choice of variables and their weights was done by logistic regression and the final result is only expressed as a probability of mortality (and not as a score). The actual MPM version incorporates models to predict mortality at admission (MPM II ), and at 24 (MPM II ), 48 (MPM II ) and 72 0 24 48 (MPM II ) hours after admission in the ICU [6] . MPM II was developed and validated in 72 0 a cohort of 19124 patients and contains 15 variables: age; three physiologic variables (coma or deep stupor, heart rate and systolic blood pressure); three chronic diseases (chronic renal failure, cirrhosis, and metastatic cancer); five acute diagnoses (acute renal failure, cardiac dysrhythmia, cerebrovascular incident, gastrointestinal bleeding, and intracranial mass effect); type of admission (medical or surgical unscheduled); mechanical ventilation and cardiopulmonary resuscitation prior to admission.
These two severity scores represent, along with APACHE III [7] , the so called third generation of severity scores: all are based on statistical modelling techniques to select and weigh the variables, rather than on subjective evaluation by panels of experts, and the computation of the risk of dying in the hospital is based on a logistic regression technique.
Independent validation in different populations is needed before general utilisation, since variations in case mix, local policies, quality of care and quality of data collection has been shown to affect the performance of the equations used to predict mortality [4, 8, 9] . Some examples in the literature shows that SAPS II did not fit well in populations from Spain [10] , Italy [11] and Portugal [12] . The same has been shown for the previous version of MPM [13] in an England and Irish population [9] and in an ICU in Spain [14] .
The aim of the present study is to evaluate the performance of SAPS II and MPM II in a 0 large independent database using current state of the art techniques [15] . APACHE III was not included in the study because the equations of the model are not in the public domain.
MATERIALS AND METHODS

THE DATABASE
The Foundation for Research on Intensive Care in Europe (FRICE) started in 1989 a series of Health Services Research projects to the multidisciplinary approach of ICUs, of which the European Intensive Care Units Studies is one. EURICUS-I, the first project of the program explores the "effects of organisation and management on the effectiveness and efficiency of ICUs in the countries of the European community". The non-medical management includes organisation, decision-making, personnel, finances and organisational culture aspects. In this study, the evaluation of severity of illness and the prediction of mortality are an essential tool for analysing the effectiveness of medical care among ICUs.
Eighty-nine ICUs of 12 European countries participated in the EURICUS-I study. In order to generate the largest possible variation on organisation and management variables, the ICUs were selected so that each country would participate with at least four to eight ICUs operating at different levels of care [16] , both in university and non-university hospitals.
Clinical and non-clinical data were pooled during the four months of the field intervention and stored and handled in Groningen, the Netherlands, at FRICE headquarters.
Informed consent of the patients or next of kin was considered unnecessary and was waived by the Institutional Review Board of the participating hospitals.
DATA COLLECTION
Data were collected during a 4-month period (October 3, 1994 to January 31, 1995) on 16060 patients consecutively admitted to 89 ICUs in 12 European countries. Since the objective of this study was the evaluation of the impact of non-clinical factors on the performance of the ICUs no exclusionary criteria were used for data collection.
Based on the literature [4, 5] , patients were described using variables that included those variables described in the original SAPS II and MPM II models. Basic demographic 0 characteristics included age; type of patient (medical and scheduled/unscheduled surgical), as well as the principal diagnostic category on admission at the ICU using a list of 78 mutually exclusive diagnoses [7] .
The daily utilisation of nursing manpower during the entire ICU stay was evaluated using the Nine Equivalents of Nursing Manpower score (NEMS), derived from the Simplified Therapeutic Intervention Scoring System [17] . This system was especially developed and validated on a large Therapeutic Intervention Scoring System (TISS) database developed by FRICE to be used in EURICUS I. The relationship of NEMS with the generally known TISS [18] is NEMS = 8.89 + 0.76 x TISS [19] .
Patient forms were blinded using code-numbered labels. These consecutively numbered labels (country/ICU/patient) issued by the Co-ordination Centre of the project allowed us to survey consecutive patient entry registration data for each ICU.
Data were entered in each ICU on standardised forms. At the Co-ordination Centre, the data were entered in a computerised database. Apart from out-of-range and logical error-checks, the forms were checked for accuracy and completeness and those with missing data were returned to local co-ordinators for further review and completion. All persons involved had access to a detailed "operations manual" with the protocols and definitions to be used during the study, and attended specially designed training sessions in each country. The protocols and definitions regarding the collection of SAPS II and MPM II data were transcribed from 0 the original publications. During the study period central support to problems and questions was provided to all participating ICUs by the Country Co-ordinators and by the Coordinating Centre.
Quality control of the data was performed at three levels. At the ICU level it was required that the ICU Co-ordinator inspects all data for completeness; double checks samples were evaluated for the first twenty patients since the beginning of the study (to access intra-rate reliability). At the Country Co-ordinator level, all forms were checked for completeness, and appropriateness of data by means of clinical judgement and site visits when necessary. At the Co-ordination Centre level checks were made for completeness of data and inter-rate reliability of data-entry in the database (5 % of the sheets entered daily were randomly extracted and controlled for exactness). During the study, site visits to all participating ICUs were performed by the Project Leader who inspected the ongoing research and ensured compliance with the study protocols.
Patients were followed to hospital discharge, and their survival status was registered. All the patients still in the hospital or with unknown outcome three months after the end of data collection were dropped from the study (113 patients). For data analyses the exclusion criteria used were those expressed in the original publications [4, 5] : patients younger than 18 years of age; readmissions; acute coronary care patients; burn patients; and post-operative patients recuperating from coronary artery by-pass surgery. To keep comparability between both systems, patients with a length of stay in the ICU shorter than 8 hours were also excluded.
DATA ANALYSIS AND STATISTICS
Z
To assess intra-observer reliability, original and quality control forms were compared and their rate of agreement evaluated using the kappa statistics [20, 21] and intraclass correlation coefficients [22, 23] .
Chi-square statistics were used to test for the statistical significance of categorical variables and t-test or one-way analysis of variance was used to assess continuous variables. All statistical tests were two-sided, and a significance level of 0.05 was used except when stated otherwise. In the comparison of the length of stay in the ICU (LOS) between survivors and non survivors, SAPS II score, SAPS II probability of mortality and MPM II probability of 0 mortality, the Mann-Whitney U test was used, since the distributions were highly skewed.
Since there is no single standard measure for describing the overall goodness of fit of multiple logistic regression models, five different methods were employed. The overall performance of the models was assessed by the use of Flora's Z score [24] . This method is based on a statistic that compares the number of survivors observed in the given data set with the number that would be predicted from the baseline survival curve. The difference is then standardised and compared to a table of the normal distribution. The statistic used was:
where S is the total number of survivors among the n patients, Pi is the probability of survival estimated by the model for the i patient and Q is 1-Pi or the probability of death estimated by the model for the i patient.
Calibration, the degree of correspondence between predicted and observed mortality, was further assessed by calibration curves and by the two chi-square statistics proposed by Hosmer and Lemeshow [25, 26] : the H test, collapsing the table based on fixed values of the estimated probabilities, and the C test, collapsing the table based on deciles of the estimated probabilities.
For assessing discrimination, or the ability of the model to discriminate between patients who live and patients who die, we used 2x2 classification tables with decision criteria of 10, 50 and 90 %, and the area under the receiver operating characteristic (ROC) curve, computed by a modification of the Wilcoxon statistics, as proposed by Hanley and McNeil [27] . Comparison of the areas under the ROC curves was done using the Z statistic with correction for the correlation introduced by studying the same sample [28] . To compare the predictions
between both models in survivors and non survivors, we also used McNemar's chi-square test.
To evaluate the uniformity of fit, or the existence of a similar fit across different subgroups, we stratified patients using several strategies: by predicted risk of dying in the hospital; by ICU; by area of Europe; by type of patient; by age group; by length of stay in the ICU; by diagnostic category of admission; by patient / nurse ratio (P/N ratio); by the number of admissions/bed/year (ABY); and by size of the hospital.
The computation of confidence intervals for the ratio of observed number of deaths versus the expected number of deaths predicted by the model (i.e. standardised mortality ratio, SMR) was done using a parametric approach, as described by Rapoport et al. [29] : ([observed number of deaths] ± z F)/(expected number of deaths), where:
n is the number of patients in the ICU, B is the SAPS II/ MPM II probability for the i i 0 th patient and z is the (1-" ) x 100 percentile of the standard normal distribution.
To evaluate the amount of variance explained by the models across ICUs, we estimated a univariate least-squares regression equation across the ICUs, taking observed mortality as a dependent variable and predicted mortality as an independent variable [30] .
Data analysis and statistics were performed using the Statistical Package for Social Sciences (SPSS) version 6.0.1 for Windows. All the analyses were done in the University of Groningen, the Netherlands.
RESULTS
THE ICUS
The 89 participating ICUs comprised a diverse sample of ICUs, in 12 European countries, with 35 (39 %) being in University Hospitals. Median hospital size was 534 beds, with 39 % of the ICU beds in hospitals with less than 500 beds, 50 % in hospitals with 500 -1000 beds, and 11 % in hospitals with more than 1000 beds. Median number of beds per ICU was 8 (interquartile range 6 to 10 beds). During the study period, data was collected on 16060 consecutive admissions.
DESCRIPTION OF DATA
Four ICUs did not collect complete data on MPM II and were excluded. After applying the 0 exclusion criteria described above, the data of 10027 (62 %) patients were available to the study.
The median number of admissions per ICU was 99 (interquartile range 66-148). Mean age was 59.3 ± 17.3 years, with a significant difference between survivors and non-survivors (58.0 ± 17.5 vs 64.2 ± 15.5 years, p < 0.001) ( Table 1 ). There was a predominance of medical patients (55.9 %); scheduled surgery patients had a lower risk of death on admission at the ICU. Non-operative cardiovascular/vascular disease was the most frequent diagnostic category on admission, accounting for 19.0 % of all diagnoses in the total sample and for 30 % of all non-operative diagnoses; with post-operative patients the most frequent diagnoses belong under the gastrointestinal category (41.5 % of all post-operative diagnoses).
During the first 24 hours in the ICU, 41.5 % of the patients were mechanically ventilated, 38.5 % used vasoactive drugs (single or multiple), and 1.7 % received dialysis. All this therapeutic interventions were significantly (p < 0.001) related with outcome. Mean nursing workload utilisation, as measured by NEMS, was 25.8 ± 9.6, and lower in survivors than non survivors (24.2 ± 8.9 vs 32.4 ± 9.6, p < 0.001).
The overall mortality in the ICU was 13.9 % and the overall mortality in the hospital 20.0 %. Median length of stay in the ICU was 2.3 days (interquartile range 1.0 to 5.9), with significant relation with outcome (survivors 2.0, interquartile range 1.0 to 4.9); non-survivors 4.0 (interquartile range 1.5 to 11.5) (p < 0.001).
Data quality analysis with data from 866 forms, which were collected, registered and entered twice (independently) into the database, demonstrated an overall good reliability for all variables. For SAPS II variables, kappa statistics were > 0.7 for acquired immunodeficiency syndrome and hematologic malignancy, and > 0.8 for metastatic cancer and type of admission. For continuous variables, intraclass correlation coefficients were between 0.5 and 0.6 for serum bilirubin 0.6 and 0.7 for urinary output, between 0.80 and 0.9 for body temperature, serum sodium, white blood cell count, serum potassium, and systolic blood pressure and higher than 0.9 for blood oxygen, serum bicarbonate, heart rate, fraction of inspired oxygen, blood urea, Glasgow coma score and age.
For MPM II variables, kappa statistics revealed a substantial agreement (kappa > 0.6) for 0 cirrhosis and cerebrovascular incident, a good agreement (kappa > 0.7) for chronic renal failure, acute renal failure, metastatic cancer, gastrointestinal bleeding and type of admission, and an almost perfect agreement (kappa > 0.8) for heart rate, intracraneal mass effect, systolic blood pressure, cardiopulmonary resuscitation prior to admission, cardiac dysrhythmia, coma or deep stupor and mechanical ventilation. The intraclass correlation coefficient for age was > 0.9. 
THE PREDICTION MODELS
The severity of illness, as described by the two scoring systems, showed large variation between ICUs. The range of medians was 2.9 % to 34.8 % for the SAPS II probability (18 to 45 points in terms of the score) and 3.9 % to 39.3 % for the MPM II probability. Both 0 scores were related to mortality (p < 0.001, Table 1 ) and to each other (Spearman correlation coefficient R = 0.780, p < 0.001). The two predicted probabilities showed a considerable dispersion, with a significant number of outliers, as already described in other studies [31] ( Figure 1 ). The models could explain only part of the variance across units, with SAPS II explaining 69.2 % of the variance and MPM II 71.3 %. the proportion of patients who died also increases. However, for SAPS II predicted risks > 40 %, the observed mortality within each risk group lay significantly below the diagonal line. Thus, the model overestimates mortality in "sicker" patients. The same pattern is present regarding the MPM II model with the shift becoming apparent at a predicted risk of death 0 of 30 %. The obvious discrepancy between the predicted and observed outcomes is also depicted by the Hosmer-Lemeshow goodness-of-fit H and C tests (p < 0.001 for both systems) (Table 2 and 3). %) and a higher overall correct classification rate (83.2 % vs 81.1 %). At a decision criteria of 90 %, sensitivity was also higher on SAPS II (11.2 % vs 7.8 %), the false positive rate were similar (0.5 % vs 0.6 %) as well as the overall correct classification similar (81.8 % vs 81.0 %). The low values observed on sensitivity, the true positive rate, have already been reported on those cases where the analysed sample have a relatively high proportion of patients with low probabilities of mortality, since relatively few patients will have a probability of mortality greater than the chosen decision criteria [32] . The crosstabulation of the predictions by both models (SAPS II and MPM II ) at a fixed 0 decision criteria (50 %) is presented in table 5. The two methods predicted the same outcome in 8795 patients. In the survivors group, the two methods predicted the same outcome in 7305 patients; in the 715 patients where the predictions did not agree, SAPS II predicted significantly (McNemar's test, p < 0.001) more patients (n = 429) than MPM II (n = 286).
0
In non-survivors, the two methods predicted the same outcome in 1490 patients; in the 517 patients where the predictions did not agree, SAPS II predicted correctly 227 whereas MPM II predicted correctly 290 (McNemar's test, p < 0.005). 
Uniformity of fit
Uniformity of fit, the existence of a similar fit across different subgroups, is of primary interest for models with good overall calibration and fit; we are obviously less interested in the "uniformity of poor fit". In the present case of a poor model fit, examination of fit in different strata (by comparison of SMRs) can be seen as a diagnostic tool for searching for causes of the lack of fit. We have considered several stratifications described below and in detail in figures 4 and 5 and tables 6 and 7.
ICU:
the differences were quite large, with mortality ratios ranging from 0.19 to 1.49 for SAPS II and between 0.18 to 1.74 for MPM II . In the case of SAPS II, SMR 95 % 0 confidence intervals do not enclose the unity in 35.3 % of the cases (26 below and 4 over); in the case of MPM II , this occurred in 31.8 % of the cases (21 below and 6 over). When 0 using SMR to evaluate performance a value of 1 means perfect agreement between observed number of deaths and those predicted by the model, a ratio < 1 means that actual deaths are lower than predicted deaths, and a value > 1 means that actual deaths are greater than predicted. Figure 4 displays SMRs based on SAPS II. As indicated by wide confidence intervals, the number of patients in some of the ICUs was not very large and the results should be interpreted with caution.
European areas:
the SMRs varied between 0.68 and 1.11 for SAPS II (in 53.9 % of the cases the 95 % confidence interval did not include the unity) and from 0.42 to 0.94 for MPM II (in 61.5 0 % of the cases the unity was not included in the 95 % confidence interval) (figure 5). The numbers of analysed patients in each area are: Poland, 392; Germany, 723; Denmark, 934; Finland, 347; The Netherlands, 988; Belgium, 1215; France, 715; United Kingdom, 687; Italy, 624; Spain -Catalonia, 978; Spain, Valencia, 1912; Portugal, 382.
Type of patient:
the number of observed deaths was overall lower than the number of predicted deaths; for SAPS II this effect was more pronounced in surgical patients (both scheduled and non scheduled surgery); for MPM II , the same pattern was present, with SMRs not included 0 within the 95 % confidence interval in all analysed groups.
Age group:
there was a trend towards increasing SMR with age, especially in the MPM II model. 
Diagnostic category:
The relationship between observed and predicted mortality demonstrated very large variations. In the SAPS II group of non-operative diagnoses, SMRs ranged from 0. 
Length of stay in the ICU:
concerning LOS in the ICU, the results do not present large differences among subgroups.
Admissions/bed/year:
for both models, a very clear trend was present with decreasing SMRs with increasing ABY.
Hospital size:
hospital size impacted SMR in a significant manner. In both models, SMRs increased in the middle range of hospital sizes (between 500 and 1000 beds). 
DISCUSSION
We analysed the performance of SAPS II and MPM II on a cohort that was independent 0 from the original database where the two instruments were developed and validated. The study was based on the assumption that the application of an outcome predictive model can only be done with confidence after the model was tested and validated in that population; otherwise, variations in case mix not accounted for by the model may have a significant impact on its performance. Although good discrimination and calibration was shown for SAPS II and MPM II in a recent study [33] , the analysed population was not really 0 independent, as it was the validation sub-group of the original population in which SAPS II (and partially MPM II ) were developed. Since the developers of the original models utilised 0 randomisation of the database to split the original database in two groups, development and validation samples, one may expect that all the variables (and non measured case mix factors) were randomly distributed in the two sub-groups; consequently, both sub-groups are expected to represent equal samples from the same underlying distribution and can not be considered true independent samples. The models analysed in this way are therefore expected to perform better than in an independent population.
In EURICUS-I study, the discriminative power of SAPS II was similar to that indicated on the original publication (lower for MPM II ). However, both models presented significant 0 differences between predicted and observed outcomes and their uniformity of fit across various stratified groups was poor, with both overestimating mortality in the most severely ill patients.
This lack of calibration can be explained, at least in part, by the differences between EURICUS-I population and European-North American / MPM patients. When we compare actual mortality with predicted mortality, the latter represents no more than the average mortality from the patients used to develop the instrument, controlled for severity of disease as measured by the included variables. Our study was realised almost 5 years later and we may suppose that the baseline has drifted, that is, that the intercept (on the logit scale of probabilities) has moved; in other words, we can attribute the lack of fit to an improvement in the quality of care in Europe in the last 5 years, mainly in the patients in the middle and high range of severity. This point can be as important as variations in case mix, since baseline characteristics and overall mortality rate are similar, except for a higher proportion of medical patients (55.9 % vs 48.4 % in original database). We do not have however information on diagnostic categories in the original databases and this fact can compromise the comparison of the populations, since it has been shown that the diagnostic category is very important for the adjustment of case mix and severity of disease [7, 34] .
It is more difficult to explain the uniformity of fit of the analysed models. It is clear that the capability of the models to adjust between subgroups was insufficient, with very large differences in mortality ratios when we stratified patients using several strategies. The same has been already observed with APACHE II in the United Kingdom [8, 35, 36] and with SAPS II in Spain [10] , and may represent an incapacity of the models to adjust to differences in case mix (not included in its construction). However, an alternative (and perhaps complementary) explanation of the lack of fit of the models can just be the presence of other factors (clinical and non-clinical), not measured by the present severity scores, that can have a huge influence on the performance of the ICUs. In this study, SAPS II performed better than MPM II , but 0 the results do not allow its use as a prognostic indicator in this population, at least without customisation. The level of customisation needed will depend on the problems detected, since no single technique can be used as a gold standard to the adaptation of a model to a different population. Some preliminary work on this field [11, 37] showed that easy modifications of the logistic equations are probably enough, but it is too soon to assume that this is always the case.
In order to understand the relevance of our results we must realise that the use of SMR as performance indicators in general intensive care is based in several assumptions; we have to accept that, in the very heterogeneous population admitted in each ICU, actual severity of illness models can control for the most important characteristics related to prognosis (age, physiologic reserve, diagnosis, physiologic derangement); if the errors resulting from the collection of data and its application are small and randomly distributed, the final difference between predicted (that is, actual mortality in a reference population used to develop the model) and observed mortality can be attributed to local differences in quality of care. This rationale has been frequently challenged in the last years [8, 35, [38] [39] [40] [41] [42] , and we can raise, at least, four main points against these assumptions.
First, the impact of intra and inter-observer variability in data collection can have an important impact in the performance of the severity scores, as already argued by others [43, 44] . This point is stressed by the actually non-existent consensus on basic definitions of some of the variables that are used in general models.
Second, general severity scores evaluate only a subset of ICU patients, since coronary care, burns, or post-operative of coronary bypass graft surgery patients were usually excluded from its development. This can seriously compromise its use when applied to ICUs with particular demographics.
Third, the application of a model to a different population can only be done once the system has been tested and validated on that population, since variations in case mix not accounted by the models can have a significant impact on its performance. This problem is obviously more important when we study highly specialised ICUs with unique patient characteristics, but even its use in general ICUs can be dependent on the characteristics of the underlying populations. This point was used by others [45] to stress the necessity of periodic evaluation and or modifications of the models, and can be specially important when the systems do not take into account diagnostic information, as is the case in SAPS II and MPM II [46] . It as 0 been argued that this criteria is especially important when the model will be used for research or quality assurance purposes [47].
Last but not the least, the equation used to transform a score to a probability of mortality does not consider the existence of factors, aggregated at ICU level, that can have an important impact on the prognosis. Actually used models assume that ICU factors (clinical and non-clinical) are either non-important or randomly distributed within large samples and that the variation between ICUs is small. If this level 2 (ICU) variation is not negligible, it may compromise the stability of the equations used to compute predicted mortality. This assumption is definitely not likely to be met for non-clinical factors (organisation and management, organisational culture) and also clinical factors (e.g. differences in medical management, therapeutic strategies) [41, 42] . Additionally, the models consider the relation between performance and severity of illness as constant and that may not be the case, since performance can vary within ICUs according to the degree of severity of the patients [48] . It is clearly the time to develop and apply modelling techniques that control for the clustering of patients within ICUs instead of assuming the independence of observations, even when that it's not true. Clearly, more research is needed in this point.
For now, we must stress the call for prudence, already made by others, on the application of general severity of illness models to analyse quality of care or performance between ICUs without previous validation [29] [30] [31] [49] [50] [51] [52] [53] [54] [55] .
